Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET
Nephrology Dialysis Transplantation, 11/05/09
Philipp T et al. – SECRET provides insights into the design and conduct of studies in this area and evidence for the utility of candesartan, which showed good safety and tolerability, improved BP control and decreased proteinuria in renal transplant recipients.
Related Articles
Beyond office sphygmomanometry: Ways to better assess blood pressure
Cleveland Clinic Journal of Medicine, 11/05/09
Relevance Score: 71%
Aliskiren Monotherapy Does Not Cause Paradoxical Blood Pressure Rises. Meta-Analysis of Data From 8 Clinical Trials
Hypertension, 11/17/09
Relevance Score: 69%
Noninvasive cardiac output and blood pressure monitoring cannot replace an invasive monitoring system in critically ill patients
BMC Anesthesiology, 10/15/09
Relevance Score: 69%
Hypertension Highlights: Updates for European Guidelines, Plus New Evidence for Blood Pressure Targets and Strategies
Internet Source, 10/14/09
Relevance Score: 69%
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Cochrane Reviews, 10/09/09
Relevance Score: 69%
Today in Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
Medium-size-vessel vasculitis
Pediatric Nephrology, 12/04/09
Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study
Atherosclerosis, 12/04/09
Renal lymphangiectasia
Scandinavian Journal of Urology and Nephrology, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


